
Beta Bionics, Inc.: updates and filings
Price
$13.18
November 19, 2026Market cap $717M
What Ploutos Investor adds for Beta Bionics
Part of Ploutos Investor, €9.99 a month
- The full history: 3 fiscal years, from 2023
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 33% since Oct 27, 2026, when the 10-Q these figures come from was filed ($21.39 then, $14.33 on Nov 18, 2026). The figures date from before that move.10-Q
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 27, 2026next Jan 27, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
September 2026
July 2026
May 2026
April 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 9, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 27, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 27, 2026Results of operationsForm8-K
- Oct 7, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 17, 2026Other material eventsForm8-K
- Sep 15, 2026Regulation FD disclosure, other material eventsForm8-K
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 29, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 29, 2026Results of operationsForm8-K
- Jul 24, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- May 22, 2026Shareholder voteForm8-K
- May 21, 2026Regulation FD disclosure, other material eventsForm8-K
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 12, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 8, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Apr 21, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 21, 2026Results of operationsForm8-K
- Apr 10, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 10, 2026Additional annual meeting materialFormDEFA14A
- Apr 10, 2026Annual meeting proxy statementFormDEF 14A
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 24, 2026Shelf registration for future offeringsFormS-3ASR
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 9, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 27, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 27, 2026 | 8-K | Results of operations | Document |
| Oct 7, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 17, 2026 | 8-K | Other material events | Document |
| Sep 15, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 29, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 29, 2026 | 8-K | Results of operations | Document |
| Jul 24, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| May 22, 2026 | 8-K | Shareholder vote | Document |
| May 21, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 12, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 8, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Apr 21, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 21, 2026 | 8-K | Results of operations | Document |
| Apr 10, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 10, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 10, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 24, 2026 | S-3ASR | Shelf registration for future offerings | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 16, 2016.
The full analysis
What do Beta Bionics's filings show?
The filings are where every one of Beta Bionics's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.